Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of May 21, 2026, PRVA trades at $23.19 with a market cap of $2.99B and a P/E ratio of 128.57. PRVA moved -0.43% today. Year to date, PRVA is -3.98%; over the trailing twelve months it is -5.46%. Its 52-week range spans $16.47 to $26.51. Analyst consensus is strong buy with an average price target of $31.33. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PRVA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRVA recently traded at $23.19. Market cap is $2.99B. P/E ratio is 128.57. Revenue is $2.25B.
| Metric | Value |
|---|---|
| Price | $23.19 |
| Market Cap | $2.99B |
| P/E Ratio | 128.57 |
| EPS | $0.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.51 |
| 52-Week Low | $16.47 |
| Volume | 440.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.25B |
| Net Income | $27.39M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.12B | $29.73M | $0.19 |
| 2023 | $1.66B | $21.03M | $0.20 |
| 2022 | $1.36B | $-12.06M | $-0.08 |
| 2021 | $966.22M | $-190.65M | $-1.83 |
15 analysts cover PRVA: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.33.